Trials / Conditions / Small Cell Lung Carcinoma Extensive Disease
Small Cell Lung Carcinoma Extensive Disease
4 registered clinical trials studyying Small Cell Lung Carcinoma Extensive Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer NCT04712903 | AstraZeneca | Phase 3 |
| Completed | Durvalumab Plus Chemotherapy in ES-SCLC (Oriental) NCT04449861 | AstraZeneca | Phase 3 |
| Active Not Recruiting | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small C NCT03043872 | AstraZeneca | Phase 3 |
| Completed | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell NCT00658580 | European Lung Cancer Working Party | Phase 3 |